Omarigliptin
Omarigliptin used for once-weekly treatment of type 2 diabetes and currently under development by Merck & Co.Reference standards of Omarigliptin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Omarigliptin - API Standards
[catalogue_number] => PA 15 73000
[category_ids] => ,79,80,69,81,78,70,82,88,
[chemical_name] =>
[weight] => 398.43
[form] => C17H20F2N4O3S
[cas] => 1226781-44-7
[pslug] => 1226781-44-7-omarigliptin-api-pa1573000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Omarigliptin - API Standards
Catalogue No.:PA 15 73000
Molecular Formula : C17H20F2N4O3S
Molecular Weight : 398.43